Validation of the Polish version of WHO-5 as a screening instrument for depression in adults with diabetes

被引:38
|
作者
Cichon, Ewelina [1 ,2 ]
Kiejna, Andrzej [1 ,2 ]
Kokoszka, Andrzej [3 ]
Gondek, Tomasz [4 ,5 ]
Rajba, Beata [1 ,2 ]
Lloyd, Cathy E. [6 ]
Sartorius, Norman [7 ]
机构
[1] WSB Univ Torun, Dept Psychol, Torun, Poland
[2] Univ Lower Silesia, Fac Educ, Dept Psychol, Psychol Res Unit Publ Hlth, Wroclaw, Poland
[3] Med Univ Warsaw, Dept Psychiat 2, Warsaw, Poland
[4] Polish Psychiat Assoc, Specialty Training Sect, Warsaw, Poland
[5] World Psychiat Assoc, Sect Educ, Zurich, Switzerland
[6] Open Univ, Fac Wellbeing Educ & Language Studies, Milton Keynes, Bucks, England
[7] Assoc Improvement Mental Hlth Programmes AMH, Geneva, Switzerland
关键词
Diabetes mellitus; Type; 2; Depression; World Health Organization; Quality of life; Psychometrics; Sensitivity and specificity; WELL-BEING INDEX; GLYCEMIC CONTROL; PRIMARY-CARE; VALIDITY; SYMPTOMS; RELIABILITY; DISTRESS; QUALITY; SCALE; OUTPATIENTS;
D O I
10.1016/j.diabres.2019.107970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The aim of this study was to validate and report the factorial analysis of the World Health Organization's 5-itemWell-being Index (WHO-5) among outpatients with type 2 diabetes. We investigated the psychometric properties of the WHO-5 and its suitability for identifying potential depressive symptoms in Polish adults with diabetes. Methods: Participants were randomly chosen among Polish diabetes outpatients and invited to participate in the cross-sectional study (N = 216). Participants completed the Polish version of the WHO-5, Problem Areas in Diabetes Scale and Patient Health Questionnaire. Results: Factor analyses identified the one-factor structure of the Polish version of the WHO-5. The internal consistency of the Polish version of the WHO-5 is satisfying. With regard to convergent validity, there were significant negative associations between the WHO-5 and PAID, the PHQ-9, HbA1c and the amount of medical complications. The AUC indicates that the WHO-5 is an effective measure for identifying depressive symptoms. The optimal cut off values of <= 12 yielded the best sensitivity/specificity trade-off for identifying depression among people with diabetes. Conclusions: The Polish version of the WHO-5 is a reliable, valid outcome measure for outpatients with type 2 diabetes and can be a useful instrument for screening for depression in people with diabetes. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: Results from Diabetes MILES - Australia
    Halliday, Jennifer A.
    Hendrieckx, Christel
    Busija, Lucy
    Browne, Jessica L.
    Nefs, Giesje
    Pouwer, Francois
    Speight, Jane
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 132 : 27 - 35
  • [2] Validation of the WHO-5 as a screening tool for depression among young adults in Malaysia
    Low, Kah-Yue
    Pheh, Kai-Shuen
    Tan, Chee-Seng
    CURRENT PSYCHOLOGY, 2023, 42 (10) : 7841 - 7844
  • [3] Validation of the WHO-5 as a screening tool for depression among young adults in Malaysia
    Kah-Yue Low
    Kai-Shuen Pheh
    Chee-Seng Tan
    Current Psychology, 2023, 42 : 7841 - 7844
  • [4] WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes
    Rauwerda, N. L.
    Tovote, K. A.
    Peeters, A. C. T. M.
    Sanderman, R.
    Emmelkamp, P. M. G.
    Schroevers, M. J.
    Fleer, J.
    DIABETIC MEDICINE, 2018, 35 (12) : 1678 - 1685
  • [5] Validation of the WHO-5 wellbeing index as a screening tool for Parkinson's disease depression
    Schneider, C. B.
    Pilhatsch, M.
    Rifati, M.
    Jost, W. H.
    Wodarz, F.
    Ebersbach, G.
    Djundja, D.
    Fuchs, G. A.
    Gies, A.
    Odin, P.
    Reifschneider, G.
    Reichmann, H.
    Wolz, M.
    Bottesi, A.
    Bauer, M.
    Storch, A.
    MOVEMENT DISORDERS, 2009, 24 : S388 - S388
  • [6] Validation of the WHO-5 Wellbeing Index in Parkinson's depression
    Schneider, C. B.
    Pilhatsch, M.
    Rifati, M.
    Jost, W. H.
    Wodarz, F.
    Ebersbach, G.
    Djundja, D.
    Fuchs, G.
    Gies, A.
    Odin, P.
    Reifschneider, G.
    Reichmann, H.
    Wolz, M.
    Bottesi, A.
    Bauer, M.
    Storch, A.
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 230 - 230
  • [7] A psychometric evaluation of the Icelandic version of the WHO-5
    Gudmundsdottir, Helga Berglind
    Olason, Dan Por
    Gudmundsdottir, Dora Gudrun
    Sigurdsson, Jon Fridrik
    SCANDINAVIAN JOURNAL OF PSYCHOLOGY, 2014, 55 (06) : 567 - 572
  • [8] The WHO-5 well-being questionnaire in type 1 diabetes: screening for depression in pediatric and young adult subjects
    Tittel, Sascha Rene
    Kulzer, Bernhard
    Warschburger, Petra
    Merz, Ulrich
    Galler, Angela
    Wagner, Christian
    Plaumann, Maike
    Siegel, Erhard
    Holl, Reinhard Walter
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2023, 36 (04): : 384 - 392
  • [9] Validation of the WHO-5 well-being index in adolescents with type 1 diabetes
    de Wit, Maartie
    Pouwer, Frans
    Gemke, Reinoud J. B. J.
    Delemarre-van de Waal, Henriette A.
    Snoek, Frank J.
    DIABETES CARE, 2007, 30 (08) : 2003 - 2006
  • [10] WHO-5 Well-being Index as a screening instrument for Parkinson's disease patients with major depression (ICD-10)
    Storch, A.
    Raming, B.
    Wallenstein, G.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S41 - S41